Financials
- Market Capitalization 20.41 M
- Employee 5
- Founded 1979
- CEO N/A
- Website www.dyadic.com
- Headquarter Delaware, United States
- FIGI BBG000L276R1
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.27
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4525 | MRKR Marker Therapeutics, Inc. - Common Stock | 1.33 USD | -2.92% | -11.33% | +14.66% | +47.78% | 22.18 M USD | ||
| 4527 | LGVN Longeveron Inc. - Class A Common stock | 6.90 USD | +2.68% | +845.21% | +871.83% | +1107.77% | 22.00 M USD | ||
| 4554 | NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.76 USD | 0.00% | -3.84% | -2.59% | -66.81% | 20.32 M USD | ||
| 4555 | AKTX Akari Therapeutics Plc - American Depositary Shares | 10.43 USD | -2.52% | +30.87% | +38.88% | +1254.55% | 20.31 M USD |